Differential Response of Immunohistochemically Defined Breast Cancer Subtypes to Anthracycline-Based Adjuvant Chemotherapy with or without Paclitaxel

BACKGROUND: The aim of the present study was to investigate the efficacy of adjuvant dose-dense sequential chemotherapy with epirubicin, paclitaxel, and CMF in subgroups of patients with high-risk operable breast cancer, according to tumor subtypes defined by immunohistochemistry (IHC). MATERIALS AN...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Fountzilas, George, Dafni, Urania, Bobos, Mattheos, Batistatou, Anna, Kotoula, Vassiliki, Trihia, Helen, Malamou-Mitsi, Vassiliki, Miliaras, Spyros, Chrisafi, Sofia, Papadopoulos, Savvas, Sotiropoulou, Maria, Filippidis, Theodoros, Gogas, Helen, Koletsa, Triantafyllia, Bafaloukos, Dimitrios, Televantou, Despina, Kalogeras, Konstantine T., Pectasides, Dimitrios, Skarlos, Dimosthenis V., Koutras, Angelos, Dimopoulos, Meletios A.
التنسيق: Artigo
اللغة:Inglês
منشور في: Public Library of Science 2012
الموضوعات:
Research Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3367950/
https://ncbi.nlm.nih.gov/pubmed/22679488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0037946
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة